Document is current
Any future updates will be listed below
-
Authors
Fujii, Takayuki https://orcid.org/0000-0002-6556-1226
Murata, Koichi
Nakabo, Shuichiro
Onishi, Akira
Murakami, Kosaku
Tanaka, Masao
Morinobu, Akio
Matsuda, Shuichi
-
Funding
Funding for this research was provided by:
Asahi Kasei Pharma Corporation
Daiichi Sankyo Company
Nagahama City
Toyooka City
- License Information
-
More Information
Article History
Received: 16 October 2025
Accepted: 2 February 2026
First Online: 10 February 2026
Declarations
:
: T.F. has received speaker fees from AbbVie GK, Astellas Pharma Inc, Asahi Kasei Pharma Corp., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Daiichi Sankyo Co. Ltd., Mitsubishi Tanabe Pharma Co., Taisho Pharmaceutical Co., Ltd., and Janssen Pharmaceutical K.K. K.Murata received research grants and/or speaker fees from Eisai Co., Ltd., Chugai Pharmaceutical Co., Ltd., Pfizer Inc., Bristol-Myers Squibb, Mitsubishi Tanabe Pharma Corporation, UCB Japan Co., Ltd., Daiichi Sankyo Co., Ltd., and Astellas Pharma Inc. A.O. received research grants and speaker fees from Pfizer Inc., Bristol Myers Squibb, Advantest, Asahi Kasei Pharma Corp., Chugai Pharmaceutical Co. Ltd., Eli Lilly Japan K. K., Ono Pharmaceutical Co., UCB Japan Co., Mitsubishi Tanabe Pharma Co., Eisai Co. Ltd., AbbVie Inc., Takeda Pharmaceutical Co. Ltd., and Daiichi Sankyo Co. Ltd. K.Murakami received speaking and/or consulting fees from AbbVie GK, Eisai Co., Ltd., Pfizer Inc., Chugai Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corp., Bristol-Myers Squibb, Daiichi Sankyo Co., Ltd., Janssen Pharmaceutical K.K., and Asahi Kasei Pharma Corp. M.T. has received research grants and/or speaker fees from AbbVie GK, Asahi Kasei Pharma Corp., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Janssen Pharmaceutical K.K., Kyowa Kirin Co., Ltd., Pfizer Inc., Taisho Pharmaceutical Co., Ltd., Tanabe Mitsubishi Pharma Corp., Teijin Pharma, Ltd., UCB Japan Co., Ltd. A.M. received honorarium and research grants from AbbVie G.K., Chugai Pharmaceutical Co. Ltd., Eli Lilly Japan K.K., Eisai Co. Ltd., Pfizer Inc., Bristol-Myers Squibb., Mitsubishi Tanabe Pharma Co., Astellas Pharma Inc., Asahi Kasei Pharma Corp., and Gilead Sciences Japan. S.M. received research grants and/or speaker fees from Takeda, Eisai, Asahi-Kasei, Astellas, Pfizer, Taisho, Mitsubishi-Tanabe, Daiichi Sankyo Co. Ltd., and Chugai. S.N. has no conflicts of interest to disclose concerning this manuscript.
